Market Size of Global Cell Signaling Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 9.80 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Cell Signaling Market Analysis
The cell signaling market is expected to register a CAGR of 9.8% over the forecast period
The COVID-19 pandemic had a profound impact on the market studied. A study published in the journal News Medical, "SARS-CoV-2 spike protein triggers cell signaling pathways in lung vascular cells" in October 2020 stated that vascular cells in the lung tissue begin to secrete signaling growth factors when exposed to just the spike protein of severe acute respiratory syndrome coronavirus without the rest of the viral components. As this signaling mechanism is potentially linked to worse outcomes in this situation, these findings could indicate new targets for the development of therapeutic agents. Thus, the high utility of cell signaling models for research about COVID-19 and respiratory diseases has offered significant growth opportunities to the market.
The significant factors for the growth of the cell signaling market include the rising incidence of chronic diseases, increased funding for cell-based research, and technological advancements in cell-based research instruments. For instance, in April 2022, as per the national library of medicine 1,898,160 new cancer cases and 608,570 cancer deaths are projected to occur in the United States 2021. There is rising funding for cell-based research across the world. For instance, according to the data available on the portal for the National Institutes of Health (NIH), an estimated USD 45 billion was granted for stem cell research in the fiscal year 2021. Similar in March 2020, increments in funding grants were observed for research of embryonic stem cells and induced pluripotent stem cells. Similar positive trends in the increment of fund grants have been observed in the European Union for cell-based research. Consequently, the increasing participation of the government in the development of cell-based research, in the form of incremental funding, is expected to drive the growth of the market studied. Other factors contributing to the growth of the market studied include the increasing incidence of chronic diseases and technological advancements in cell-based research instruments.
However, the high cost of cell signaling systems and ethical issues related to embryonic stem cell signaling research are likely to hinder the market growth.
